<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04395534</url>
  </required_header>
  <id_info>
    <org_study_id>R1 - CME</org_study_id>
    <nct_id>NCT04395534</nct_id>
  </id_info>
  <brief_title>Non-microradical Resection Margin as a Predictor for Recurrence After Complete Mesocolic Excision</brief_title>
  <official_title>Non-microradical Resection Margin as a Predictor for Recurrence After Complete Mesocolic Excision: a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Claus Anders Bertelsen, PhD, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nordsjaellands Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aim to investigate the value of the current definition of microradical resection
      margin in colon cancer. Is the distance from tumor tissue to resection margin and the site of
      any clinically prognostic importance if complete mesocolic excision has been performed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2008</start_date>
  <completion_date type="Actual">March 15, 2020</completion_date>
  <primary_completion_date type="Actual">March 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence</measure>
    <time_frame>3 years</time_frame>
    <description>Any type of recurrence</description>
  </primary_outcome>
  <enrollment type="Actual">276</enrollment>
  <condition>Colon Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Complete mesocolic excision</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing elective curative intended complete mesocolic excision for primary
        colon adenocarcinoma at Nordsjællands Hospital in Hillerød, Denmark
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing elective curative intended complete mesocolic excision for primary colon
             adenocarcinoma at Nordsjællands Hospital in Hillerød, Denmark

          -  International Union Against Cancer (Union Internationale Contre le Cancer - UICC)
             stage III - pT1-4, pN1-2 cM0 (gastroepiploic and infrapyloric lymph node metastases
             are not considered as distant metastases)

          -  Resident in Denmark at the time of surgery.

        Exclusion Criteria:

          -  Patients who did not undergo macroradical resections

          -  Synchronous colorectal cancer

          -  Venous invasion at central venous ligation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 15, 2020</study_first_submitted>
  <study_first_submitted_qc>May 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nordsjaellands Hospital</investigator_affiliation>
    <investigator_full_name>Claus Anders Bertelsen, PhD, MD</investigator_full_name>
    <investigator_title>Consultant Colorectal Surgeon, Associate Professor, Head of Research Department of Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

